These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia. Xue J, Liu Y, Ji T, Zhao A, Liang Y, Deng H, Wang Q, Zhang Y, Yang L, Yang A. Nucl Med Commun; 2018 Dec; 39(12):1129-1137. PubMed ID: 30239472 [Abstract] [Full Text] [Related]
7. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism. Gallowitsch HJ, Mikosch P, Kresnik E, Gomez I, Lind P. Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734 [Abstract] [Full Text] [Related]
16. The feasibility of anterior 180° 99m Tc-sestamibi parathyroid SPECT/CT. Cheng JL, Hsu CC, Wang PW, Sung KC, Chiu NT, Chiu LY, Huang YC. Ann Nucl Med; 2021 Feb; 35(2):203-210. PubMed ID: 33389667 [Abstract] [Full Text] [Related]
17. Are 99mTC-Sestamibi Single Photon Emission Computed Tomography Scan Results Associated to the Parathyroid Cell Type in Primary Hyperparathyroidism? Romero-Velez G, Noureldine SI, Rahman M, Bena JF, Burneikis T, Jin J. J Surg Res; 2024 Jan; 293():517-524. PubMed ID: 37827030 [Abstract] [Full Text] [Related]
18. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ, Maheux P. J Nucl Med; 1998 Aug; 39(8):1441-4. PubMed ID: 9708524 [Abstract] [Full Text] [Related]
19. Efficacy of ultrasonography and Tc-99m MIBI SPECT/CT in preoperative localization of parathyroid adenomas causing primary hyperthyroidism. Lu R, Zhao W, Yin L, Guo R, Wei B, Jin M, Zhou X, Zhang C, Lv X. BMC Med Imaging; 2021 May 21; 21(1):87. PubMed ID: 34020602 [Abstract] [Full Text] [Related]
20. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS. J Nucl Med; 1997 Jun 21; 38(6):834-9. PubMed ID: 9189125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]